tissue factor pathway inhibitor (Brinkmann Instruments)
Structured Review
Tissue Factor Pathway Inhibitor, supplied by Brinkmann Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tissue+factor+pathway+inhibitor/human+tissue+factor+pathway+inhibitor+gene+encoding++p151l++tfpi/10__1016_slash_s2352___3026_ascii40_24_ascii41_00348___x-62-13-1
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Non-replacement therapy for people with haemophilia B: another step towards health equity Article Snippet: The past 10 years have seen an expansion in treatment possibilities for people with haemophilia, driven by the need for better protection against bleeding episodes, more efficient prevention of joint damage long-term, and an effective prophylactic strategy for people with inhibitors.. The introduction of replacement therapies with modified pharmacokinetic properties (referred to as extended half-life products) and, soon after, of nonreplacement therapies has revolutionised treatment approaches and outcomes.. Extended half-life products provide better protection than standard half-life replacement therapies by allowing for much higher trough concentrations, as recom mended by several guidelines, and a more sustainable treatment burden with fewer intra venous injections during regular prophylaxis. Clinical Proteomics:Article Title: Qualitative and Quantitative Analysis of Proteome and Peptidome of Human Follicular Fluid Using Multiple Samples from Single Donor with LC-MS and SWATH Methodology. Article Snippet: Subscriber access provided by NEW YORK UNIV Journal of Proteome Research is published by the American Chemical Society.. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society.. Copyright © American Chemical Society. Expressing:Article Title: Abstracts Article Snippet: not submitted |
